Indirect presynaptic modulation of striatal dopamine release by GABA(B) receptors in the rat substantia nigra.
Norbert Balon, Badreddine Kriem, Michel Weiss, Jean-Claude Rostain
Index: Neurosci. Lett. 325(1) , 33-6, (2002)
Full Text: HTML
Abstract
Regulation of striatal dopamine release by gamma-aminobutyric acid (GABA) neurotransmission was investigated using voltammetry in freely moving rats, following focal injection of the GABA(B) receptor agonist baclofen or the GABA(B) receptor antagonist 5-aminovaleric acid (5-AVA) in either the substantia nigra pars reticulata (SNr) or the substantia nigra pars compacta (SNc). Administration in the SNr of baclofen and 5-AVA at the dose of 2 pg, but not of 0.2 pg, resulted in a decrease and an increase in striatal dopamine release, respectively. In contrast, when injected in the SNc, 5-AVA only produced a transient increase in striatal dopamine release, while baclofen remained ineffective. This suggests that GABA(B) receptors in the SNr, but not the SNc, may play a major role in the control of nigrostriatal dopamine (DA) activity and the release of DA in the striatum.
Related Compounds
Related Articles:
2014-10-01
[J. Am. Soc. Mass Spectrom. 25(10) , 1694-704, (2014)]
2011-06-01
[Kidney Int. 79(11) , 1244-53, (2011)]
2011-04-01
[Anal. Chem. 83(7) , 2705-11, (2011)]
2009-05-15
[Anal. Chem. 81(10) , 3919-32, (2009)]
2011-05-01
[Eur. J. Med. Chem. 46 , 1483-98, (2011)]